{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-22-001317","form_type":"8-K","ticker":"APHD","cik":"0001490054","company_name":"VERDE BIO HOLDINGS, INC.","filed_at":"2022-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.889069+00:00","generated_at":"2026-06-25T05:26:46.375691+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Verde Bio enters $6M Series C Preferred financing with GHS Investments","bullets":["Initial close of 125 preferred shares at $1,000 each, raising $125,000; total up to 6,000 shares ($6M).","200 commitment shares issued pro-rata; 8% annual dividend payable quarterly in cash or stock.","Amended Certificate of Designation increases authorized Series C shares to 7,600.","Additional closings of 250 shares each subject to equity conditions (price >$0.005, volume >$60K/day)."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-22-001317","json":"https://secwatch.observer/filing/0001096906-22-001317.json","markdown":"https://secwatch.observer/filing/0001096906-22-001317.md","text":"https://secwatch.observer/filing/0001096906-22-001317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1490054/000109690622001317/0001096906-22-001317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1490054/000109690622001317/vbhi-20220527.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:26:46.375691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}